Leidos (LDOS) Downgraded by Zacks Investment Research
Leidos (NYSE:LDOS) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday.
According to Zacks, “Leidos Holdings, Inc. (Leidos) is a holding company whose direct 100%-owned subsidiaries and principal operating companies are Leidos, Inc. and Leidos Innovations Corporation. Leidos is a global science and technology company that provides technology and engineering services and solutions in the defense, intelligence, civil and health markets. Their domestic customers include agencies of the U.S. Department of Defense, the U.S. Intelligence Community, the U.S. Department of Homeland Security, the Federal Aviation Administration, the Department of Health and Human Services, other U.S. Government civil agencies and state and local government agencies. Their international customers include foreign governments and their agencies, primarily located in the United Kingdom, the Middle East and Australia. “
A number of other research analysts also recently issued reports on the company. Citigroup boosted their price objective on Leidos from $65.00 to $71.00 and gave the company a “buy” rating in a research note on Friday, November 3rd. Wells Fargo & Co raised Leidos from a “market perform” rating to an “outperform” rating and set a $69.00 price target on the stock in a research note on Wednesday, October 25th. Cowen reaffirmed a “buy” rating and set a $72.00 price target on shares of Leidos in a research note on Tuesday, December 19th. Stifel Nicolaus reaffirmed a “hold” rating and set a $68.00 price target on shares of Leidos in a research note on Tuesday, November 21st. Finally, TheStreet raised Leidos from a “c+” rating to a “b+” rating in a research note on Monday, October 2nd. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $69.33.
Leidos (NYSE LDOS) opened at $66.38 on Tuesday. The stock has a market capitalization of $9,790.00, a PE ratio of 35.50, a PEG ratio of 1.70 and a beta of 1.66. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.27 and a quick ratio of 1.03. Leidos has a 52 week low of $47.81 and a 52 week high of $66.44.
Leidos (NYSE:LDOS) last announced its quarterly earnings data on Thursday, November 2nd. The aerospace company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.81 by $0.14. The company had revenue of $2.50 billion for the quarter, compared to the consensus estimate of $2.55 billion. Leidos had a return on equity of 17.20% and a net margin of 3.04%. The firm’s revenue was up 34.0% compared to the same quarter last year. During the same period in the previous year, the business earned $1.25 EPS. sell-side analysts predict that Leidos will post 3.7 earnings per share for the current fiscal year.
In related news, Director John P. Jumper sold 61,212 shares of the company’s stock in a transaction that occurred on Tuesday, December 12th. The stock was sold at an average price of $64.06, for a total transaction of $3,921,240.72. Following the transaction, the director now directly owns 306,709 shares of the company’s stock, valued at approximately $19,647,778.54. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.70% of the stock is currently owned by corporate insiders.
Institutional investors and hedge funds have recently modified their holdings of the business. Northwestern Mutual Wealth Management Co. increased its holdings in Leidos by 0.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,975 shares of the aerospace company’s stock worth $102,000 after purchasing an additional 18 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. increased its holdings in Leidos by 31.2% during the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 2,158 shares of the aerospace company’s stock worth $111,000 after purchasing an additional 513 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Leidos by 263.0% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 3,111 shares of the aerospace company’s stock worth $161,000 after purchasing an additional 2,254 shares in the last quarter. Hanseatic Management Services Inc. bought a new stake in Leidos during the 2nd quarter worth approximately $174,000. Finally, Ontario Teachers Pension Plan Board bought a new stake in Leidos during the 2nd quarter worth approximately $209,000. 73.48% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.watchlistnews.com/leidos-ldos-downgraded-by-zacks-investment-research/1799467.html.
Leidos Company Profile
Leidos Holdings, Inc (Leidos) is a science and technology solutions company focused on delivering solutions primarily in the areas of national security, health and engineering. The Company is a holding company whose direct 100%-owned subsidiary is Leidos, Inc, which delivers science and technology solutions in the areas of national security, health and engineering to agencies of the United States Department of Defense (DoD), the intelligence community, the United States Department of Homeland Security, and other United States Government civil agencies, state and local government agencies, foreign governments and customers across a variety of commercial markets.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with Analyst Ratings Network's FREE daily email newsletter.